These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4200989)

  • 1. Disposition of clonixin (2-(3-chloro-o-toluidino) nicotinic acid) in humans.
    Katchen B; Buxbaum S; Ning J
    J Pharmacol Exp Ther; 1973 Oct; 187(1):152-7. PubMed ID: 4200989
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism and pharmacokinetics of a new nonsteroid, anti-inflammatory agent, 2-(3-chloro-o-toluidino) nicotinic acid (clonixin) in rats, dogs and monkeys.
    Katchen B; Buxbaum S; Meyer J; Ning J
    J Pharmacol Exp Ther; 1973 Feb; 184(2):453-64. PubMed ID: 4631713
    [No Abstract]   [Full Text] [Related]  

  • 3. An improved TLC method for the detection of flunixin in equine serum.
    Pemberton AD; Slater JS; Milne EM
    Res Vet Sci; 1989 Nov; 47(3):406-7. PubMed ID: 2595101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of C14-ICI 54,450 (myalex) in various species--an in vivo NIH shift.
    Foulkes DM
    J Pharmacol Exp Ther; 1970 Mar; 172(1):115-21. PubMed ID: 4984667
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic patterns of 4-allyloxy-3-chlorophenylacetic acid in rat, rabbit, dog, monkey, and man.
    Roncucci R; Simon MJ; Lambelin G; Gillet C; Staquet M; Buu-Hoï NP
    Arzneimittelforschung; 1970 May; 20(5):631-6. PubMed ID: 4987566
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.
    Lan SJ; Chando TJ; Weliky I; Schreiber EC
    J Pharmacol Exp Ther; 1973 Aug; 186(2):323-30. PubMed ID: 4719785
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the controlled experiment of new anti-inflammatory agent, Clonixin, in chronic rheumatoid arthritis].
    Shiokawa Y; Honma M; Irimajiri S
    Ryumachi; 1973 Jan; 12(4):366-72. PubMed ID: 4576980
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition of SCH 10595 in animals and man.
    Symchowicz S; Staub M
    J Pharmacol Exp Ther; 1974 Nov; 191(2):324-30. PubMed ID: 4214231
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kinetics of the metabolism of 9 -fluorhydrocortisone].
    Garbe A; Wenzl H
    Arzneimittelforschung; 1971 Aug; 21(8):Suppl:1127-32. PubMed ID: 4998229
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic and pharmacokinetic study of bucloxic acid. II. Pharmacokinetic study in the baboon.
    Chasseaud LF; Fry BJ; Gros PM
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1390-7. PubMed ID: 4480069
    [No Abstract]   [Full Text] [Related]  

  • 11. Aniline hydroxylase microassay suitable for needle biopsy specimens: effects of phosphate and pyrophosphate on aniline hydroxylation.
    Gang H; Lieber CS; Rubin E
    J Pharmacol Exp Ther; 1972 Oct; 183(1):218-25. PubMed ID: 4404114
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of diazoxide in man and experimental animals.
    Pruitt AW; Faraj BA; Dayton PG
    J Pharmacol Exp Ther; 1974 Jan; 188(1):248-56. PubMed ID: 4203373
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiological disposition and metabolism of levo-methadone-1- 3 H in nontolerant and tolerant rats.
    Misra AL; Mulé SJ; Bloch R; Vadlamani NL
    J Pharmacol Exp Ther; 1973 May; 185(2):287-99. PubMed ID: 4703824
    [No Abstract]   [Full Text] [Related]  

  • 14. Dioxoisoquinoline-4-carboxanilides, novel nonsteroidal anti-inflammatory agents with a species-specific effect on basal metabolism.
    Wiseman EH; Gralla EJ; Chiaini J; Migliardi JR; Chang YH
    J Pharmacol Exp Ther; 1970 Mar; 172(1):138-53. PubMed ID: 4190453
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism of niflumic acid in man].
    Boissier JR; Tillement JP; Larousse C
    Therapie; 1971; 26(1):211-8. PubMed ID: 5554765
    [No Abstract]   [Full Text] [Related]  

  • 16. Absorption, excretion and metabolism of a new analgesic and anti-inflammatory drug K 4277 in rats, guinea pigs, rabbits and dogs.
    Goldaniga GC; Pianezzola E; Valzelli G
    Arzneimittelforschung; 1974 Oct; 24(10):1603-6. PubMed ID: 4479768
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of 7- 14 C-nicotinic acid metabolism in the human blood platelet by anti-inflammatory drugs.
    Gaut ZN; Solomon HM
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):547-52. PubMed ID: 4400175
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stability of tritium-labelled clonixin [2-(2'-methyl-3"chloro) anilino-nicotinic acid] of high specifc activity.
    Hata K; Takagi M; Koga K; Shigematsu A
    Radioisotopes; 1977 Jan; 26(1):30-2. PubMed ID: 577020
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical effects of aromatic compounds. 3. Ferrihaemoglobinaemia and the presence of p-hydroxy-o-toluidine in human blood after the administration of prilocaine.
    Hjelm M; Ragnarsson B; Wistrand P
    Biochem Pharmacol; 1972 Nov; 21(21):2825-34. PubMed ID: 4646804
    [No Abstract]   [Full Text] [Related]  

  • 20. The disposition of butriptyline in rats, dogs and man.
    Cameron BD; Chasscaud LF; Lewis JD; Taylor T
    Arzneimittelforschung; 1974 Jan; 24(1):93-6. PubMed ID: 4406119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.